Skip to main content
Log in

Making the Proper Choices on Education for the Pharmaceutical Industry

  • Current Opinion
  • Published:
Pharmaceutical Medicine Aims and scope Submit manuscript

Abstract

In this interview, Professor Peter Stonier shares his personal perspectives and experience with Carl Naraynassamy over various aspects of professionalism in the pharmaceutical industry, and particularly on the place of education, competence, and professional bodies. Professor Stonier explains his support for the revalidation programme for pharmaceutical physicians in the UK, and argues the merits of inter-disciplinary learning, and the e-portfolio for a record of training and life-long learning. He also calls for more proactive risk management and less crisis management, a stronger leadership base, and for the influence of accountants and commercial people in the pharmaceutical industry to be tempered. Senior decision makers in the pharmaceutical industry, educators as well as all medicine development scientists should find this discussion of interest.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Notes

  1. http://www.pharmatrain.eu/.

  2. http://www.imi.europa.eu/.

Conflict of interest

Both Peter Stonier and Carl Naraynassamy confirm that they have received no external funding in relation to this interview. Carl Naraynassamy declares that there are no potential conflicts of interest in the generation of this document. Peter Stonier is Board Director of the PharmaTrain Federation, a not-for-profit membership organisation fostering education and training in pharmaceutical medicine/medicines development science in the EEA. He is Programme Director of the UK postgraduate specialty training programme in Pharmaceutical Medicine with the Pharmaceutical Medicine Virtual Deanery. He is visiting Professor in Pharmaceutical Medicine at King’s College London, Institute of Pharmaceutical Sciences, Faculty of Life Sciences and Medicine.

These are the personal views of Professor Stonier that in no way should be deemed to represent the views of any organisation with which he is currently associated.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carl Naraynassamy.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Naraynassamy, C. Making the Proper Choices on Education for the Pharmaceutical Industry. Pharm Med 29, 7–10 (2015). https://doi.org/10.1007/s40290-015-0087-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40290-015-0087-5

Keywords

Navigation